BIOFACTORY S.A. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.6 PLN | -.--% |
|
-.--% | +22.99% |
| May. 15 | Biofactory S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Feb. 14 | Biofactory S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 5.135 | 5.135 | 5.211 | 7.988 | 7.798 | 7.113 |
| Enterprise Value (EV) 1 | 5.135 | 11.8 | 10.79 | 11.64 | 11.76 | 11.73 |
| P/E ratio | 10.1 x | 11.1 x | 61.3 x | 7.51 x | 7.36 x | -35 x |
| Yield | 4.81% | - | 5.47% | 6.43% | 7.32% | - |
| Capitalization / Revenue | 0.42 x | 0.4 x | 0.45 x | 0.5 x | 0.47 x | 0.49 x |
| EV / Revenue | 0.42 x | 0.4 x | 0.45 x | 0.5 x | 0.47 x | 0.49 x |
| EV / EBITDA | 2.72 x | 2.91 x | 4.04 x | 3.4 x | 3 x | 5.93 x |
| EV / FCF | 8.57 x | 50.5 x | 4.45 x | 4.06 x | 216 x | 39.6 x |
| FCF Yield | 11.7% | 1.98% | 22.5% | 24.7% | 0.46% | 2.52% |
| Price to Book | - | 0.94 x | 0.93 x | 1.26 x | 1.13 x | 1.17 x |
| Nbr of stocks (in thousands) | 1,902 | 1,902 | 1,902 | 1,902 | 1,902 | 1,902 |
| Reference price 2 | 2.700 | 2.700 | 2.740 | 4.200 | 4.100 | 3.740 |
| Announcement Date | 4/30/19 | 4/30/20 | 4/30/21 | 4/29/22 | 4/27/23 | 4/12/24 |
1PLN in Million2PLN
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 12.12 | 12.9 | 11.52 | 15.87 | 16.75 | 14.62 |
| EBITDA 1 | 1.885 | 1.766 | 1.289 | 2.349 | 2.598 | 1.2 |
| EBIT 1 | 1.026 | 0.9006 | 0.4151 | 1.503 | 1.73 | 0.3062 |
| Operating Margin | 8.47% | 6.98% | 3.61% | 9.47% | 10.33% | 2.09% |
| Earnings before Tax (EBT) 1 | 0.6405 | 0.574 | 0.1145 | 1.178 | 1.325 | -0.1829 |
| Net income 1 | 0.5098 | 0.4619 | 0.085 | 1.064 | 1.059 | -0.2034 |
| Net margin | 4.21% | 3.58% | 0.74% | 6.71% | 6.32% | -1.39% |
| EPS 2 | 0.2680 | 0.2429 | 0.0447 | 0.5594 | 0.5568 | -0.1069 |
| Free Cash Flow 1 | 0.5994 | 0.1016 | 1.172 | 1.97 | 0.0361 | 0.1795 |
| FCF margin | 4.94% | 0.79% | 10.18% | 12.41% | 0.22% | 1.23% |
| FCF Conversion (EBITDA) | 31.8% | 5.75% | 90.91% | 83.84% | 1.39% | 14.95% |
| FCF Conversion (Net income) | 117.57% | 21.99% | 1,378.19% | 185.13% | 3.41% | - |
| Dividend per Share 2 | 0.1300 | - | 0.1500 | 0.2700 | 0.3000 | - |
| Announcement Date | 4/30/19 | 4/30/20 | 4/30/21 | 4/29/22 | 4/27/23 | 4/12/24 |
1PLN in Million2PLN
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt | - | 6.66 | 5.58 | 3.66 | 3.96 | 4.62 |
| Net Cash position | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 3.771 x | 4.33 x | 1.556 x | 1.524 x | 3.847 x |
| Free Cash Flow 1 | 0.6 | 0.1 | 1.17 | 1.97 | 0.04 | 0.18 |
| ROE (net income / shareholders' equity) | 9.95% | 8.58% | 1.54% | 17.8% | 16% | -3.13% |
| ROA (Net income/ Total Assets) | 4.85% | 4.2% | 1.92% | 7.01% | 8.03% | 1.43% |
| Assets 1 | 10.5 | 10.99 | 4.432 | 15.18 | 13.2 | -14.23 |
| Book Value Per Share | - | 2.890 | 2.930 | 3.340 | 3.630 | 3.200 |
| Cash Flow per Share | - | 0.0100 | 0.2300 | 1.050 | 0.5600 | 0.0800 |
| Capex 1 | 0.46 | 0.87 | 0.09 | 0.6 | 0.4 | 0.35 |
| Capex / Sales | 3.8% | 6.77% | 0.74% | 3.8% | 2.39% | 2.41% |
| Announcement Date | 4/30/19 | 4/30/20 | 4/30/21 | 4/29/22 | 4/27/23 | 4/12/24 |
1PLN in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- BFC Stock
- Financials Biofactory S.A.
